Public trust in scientists for cancer information across political ideologies in the US

JAMA Network Open

2025-12-04

(Press-News.org) About The Study: In this survey study of U.S. adults, overall trust in scientists as sources of cancer information was high. However, a clear ideological gradient suggests the need for tailored messaging and trusted messengers to reach politically diverse audiences with evidence-based cancer information.

Corresponding Author: To contact the corresponding author, Christopher W. Wheldon, PhD, email chris.wheldon@temple.edu.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2025.46818)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2025.46818?guestAccessKey=1b34668e-afe8-4888-aa3d-dd05b3b83eff&utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120425

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

END

ELSE PRESS RELEASES FROM THIS DATE:

Adverse experiences, protective factors, and obesity in Latinx and Hispanic youths

2025-12-04

About The Study: The findings of this study suggest that adverse childhood experiences may increase youth obesity risk, but promotion of resiliency-focused skills may help improve pediatric weight trajectories among disproportionately impacted populations. Corresponding Author: To contact the corresponding author, Shana Adise, PhD, email shana.adise@uga.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2025.47104) Editor’s Note: Please see the article for additional information, including other ...

Researchers identify bacterial enzyme that can cause fatal heart conditions with pneumonia infections

2025-12-04

Under Embargo Until Dec. 4 at 11 am EST CONTACT: Heide Aungst HAungst@som.umaryland.edu 216-970-5773 (cell) Researchers Identify Bacterial Enzyme that can Cause Fatal Heart Conditions with Pneumonia Infections The Enzyme Could Become a Target for Future Vaccines or Drug Therapies BALTIMORE, Dec. 4, 2025: Pneumonia is a disease that burdens the healthcare system with more that 1.2 million emergency room visits each year and more than 41,000 adult deaths in the United States. Worldwide, more than one million children under the age of five die of ...

Single enzyme failure found to drive neuron loss in dementia

2025-12-04

Researchers at Helmholtz Munich, the Technical University of Munich and the LMU University Hospital Munich uncovered a mechanism that protects nerve cells from premature cell death, known as ferroptosis. The study provides the first molecular evidence that ferroptosis can drive neurodegeneration in the human brain. These findings open up new avenues for developing future therapies – particularly for severe early-onset childhood dementia. The Enzyme That Protects Nerve Cells Why do neurons die in dementia – and can this process be slowed down? An international team led by Prof. Marcus Conrad, Director of the Institute of Metabolism and Cell Death ...

Sudden cardiac death risk falls in colorectal cancer, but disparities persist

2025-12-04

“Persistent discrepancies by gender, race, and geography underline the importance of individualized cardio-oncology surveillance, equitable preventative initiatives, and focused public health interventions.” BUFFALO, NY — December 4, 2025 — A new research paper was published in Volume 12 of Oncoscience on November 7, 2025, titled “Temporal trends and disparities in sudden cardiac death among colorectal cancer patients: A nationwide study.” In this study, led by first author Eric Sanji of Magnolia Regional Health Center, researchers examined ...

From lab to clinic: CU Anschutz launches Phase 1 clinical trial of promising combination therapy for resistant ovarian cancer

2025-12-04

Researchers at the University of Colorado Cancer Center have discovered a novel therapy combination that could offer new hope to ovarian cancer patients who do not respond to existing treatments. Conducted entirely at the University of Colorado Anschutz, this research has advanced from the laboratory to a Phase 1 clinical trial on the campus. The findings, published today in Cancer Research Communications, outline a promising strategy that combines a PARP inhibitor, a targeted drug used to treat certain types of ovarian cancer, with ...

Renuka Iyer, MD, named new Chief Medical Officer for National Comprehensive Cancer Network (NCCN)

2025-12-04

PLYMOUTH MEETING, PA [December 4, 2025] — The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers that publishes free evidence-based, expert consensus-driven guidelines for cancer prevention and care—today announced the hiring of Renuka Iyer, MD, as the new Chief Medical Officer (CMO) for the organization. Dr. Iyer has a long history of leadership and innovation in oncology. She currently serves as a Professor of Oncology for Roswell Park Comprehensive ...

New organ-on-a-chip platform allows the testing of cancer vaccine efficacy in aging populations

2025-12-04

Los Angeles, CA – December 4, 2025 – Dr. Vadim Jucaud’s lab at the Terasaki Institute has introduced a new organ-on-a-chip platform that recapitulates age-dependent immune responses, offering a more accurate testing bed for evaluating cancer vaccine performance in older adults, the population most affected by cancer and often overlooked in traditional preclinical testing. Immunosenescence, the natural decline of the immune system with age, significantly reduces the effectiveness of cancer vaccines. Yet, despite its clinical importance, age-related immune decline is seldom incorporated into vaccine development pipelines. Current 2D ...

No, we don't need more and more data about nature. We need more people to use the data

2025-12-04

Europe is gobbling up almost 50 square metres of land and topsoil per second. And Norway tops the list of European countries with the most land lost to construction per person, according to a study initiated by the Arena for Journalism in Europe and the Norwegian Broadcasting Corporation, NRK. At the same time, we have never had access to more data and knowledge about nature and the ecosystems we are building on. "We are acquiring more and more ecological data as a basis for land-use planning. Then you would think that the decisions we make ...

Research explores effect of parental depression symptoms on children’s reward processing

2025-12-04

In newly published research, Binghamton University doctoral student Elana Israel, MS ’22, explores which depressive symptoms largely affect children’s neural responses to feedback. Depression in parents can affect a child’s reward processing, or how their brains react to positive and negative feedback. Israel and Psychology Professor Brandon Gibb, director of the Mood Disorders Institute, explored whether a specific symptom of depression in parents known as anhedonia, a loss of interest or pleasure in things, may be specifically responsible for this link. The study will be included in ...

Phonetic or morpholexical issues? New study reveals L2 French ambiguity

2025-12-04

Ambiguous speech production is a common challenge for learners of a second language (L2), but identifying whether the problem lies in pronunciation or deeper linguistic processing is not always straightforward. A new study conducted by Professor Sylvain Detey from Waseda University, with Dr. Verdiana De Fino from IRIT, UT3, University of Toulouse & Archean Labs, France, and Dr. Lionel Fontan, Head of Archean Labs, France, sheds light on this distinction. Their study was published on October 30, 2025, in the journal Language Testing in Asia. The researchers sought to determine whether ambiguous speech errors made by Japanese learners of French could be better categorized through a combined ...

LAST 30 PRESS RELEASES:

Scientists trace microplastics in fertilizer from fields to the beach

The Lancet Obstetrics, Gynecology, & Women’s Health: Taking paracetamol during pregnancy does not increase risk of autism, ADHD or intellectual disabilities, confirms new gold-standard evidence review